Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Mar 16;23(2):344-350.
doi: 10.17305/bjbms.2022.6973.

Evaluation of qualitative and quantitative taste alterations in COVID-19

Affiliations
Observational Study

Evaluation of qualitative and quantitative taste alterations in COVID-19

Angela Pia Cazzolla et al. Biomol Biomed. .

Abstract

A large percentage of coronavirus disease 2019 (COVID-19) patients have taste dysfunction. Interleukin 6 (IL-6) levels in mild and moderate COVID-19 patients with the type (quantitative or qualitative) of taste disorders were compared in this observational study. The 208 COVID-19 patients (118 men and 90 women) revealing only taste dysfunctions as prodromic symptoms were classified as mild and moderate patients. Survey results were used to evaluate the taste disorder. The IL-6 levels were measured using a chemiluminescence assay. Statistical analysis was conducted using the Wilcoxon rank, Welch's, and Mann-Whitney tests. The findings revealed that neither the presence of dysgeusia or phantogeusia nor the perception of sour and salty, differed statistically significantly between moderate and mild patients (P > 0.05). But between moderate and mild patients, there were statistically significant differences in how umami, bitter, sweet, and parageusia were perceived (P < 0.05). There was an impairment of multiple tastes up to ageusia in patients with high IL-6 levels. The findings demonstrated that parageusia and dysfunctions in umami, bitter, and sweet taste perception can be indicators of more severe forms of COVID-19.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Authors declare no conflicts of interest.

Figures

Figure 1.
Figure 1.
Distribution of IL-6 values. (A) In total sample, (B) in mild patients, and (C) in moderate patients. IL-6: Interleukin 6.
Figure 2.
Figure 2.
Summary scheme of the probable mechanisms of onset of taste disorders (qualitative and quantitative). GPCR: G-protein-coupled receptors; IL: Interleukin; INF: Interferon; TNF-α: Tumor necrosis factor α; ROS: Reactive oxygen species.

References

    1. Cirillo N, Bizzoca ME, Lo Muzio E, Cazzolla AP, Lo Muzio L. Gustatory dysfunction in COVID-19 patients: a rapid systematic review on 27,687 cases. Acta Odontologica Scandinavica. 2021;79:418–425. https://doi.org/10.1080/00016357.2020.1869828. - PubMed
    1. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251–61. https://doi.org/10.1007/s00405-020-05965-1. - PMC - PubMed
    1. Santacroce L, Charitos IA, Del Prete R. COVID-19 in Italy: an overview from the first case to date. Electron J Gen Med. 2020;17(6):em235. https://doi.org/10.29333/ejgm/7926.
    1. Santacroce L, Bottalico L, Charitos IA. The impact of COVID-19 on Italy: a lesson for the future. Int J Occup Environ Med. 2020;11(3):151–2. https://doi.org/10.34172/ijoem.2020.1984. - PMC - PubMed
    1. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol. Head Neck Surg. 2020;163(1):3–11. https://doi.org/10.1177/0194599820926473. - PubMed

Publication types